"The consistency and accuracy of the device in the recognition of disease allows a real choice to be made by clinicians, parents and patients. It's easy to use and creates a real talking point with the patients."

Leigh Hunter

Latest

FDA 510(k) clearance granted

CarieScan has received 510(k) clearance from the US Food & Drug Administration ("FDA"), allowing the CarieScan PRO™ to be marketed in the USA.

 

 

Investor News


Latest News and company information
Go

Share Price

Stock Ticker: 3D.P.PL

£0.09 +1
Share price correct at: Tue Feb 09 2010 02:33:25